144 related articles for article (PubMed ID: 12749728)
41. Urinary biomarkers in prostate cancer detection and monitoring progression.
Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
[TBL] [Abstract][Full Text] [Related]
42. Innovative biomarkers for prostate cancer early diagnosis and progression.
You J; Cozzi P; Walsh B; Willcox M; Kearsley J; Russell P; Li Y
Crit Rev Oncol Hematol; 2010 Jan; 73(1):10-22. PubMed ID: 19328712
[TBL] [Abstract][Full Text] [Related]
43. [Research Progress of Biomakers Proteomics-based in Lung Cancer].
Xie H; Chen Z; Wang G
Zhongguo Fei Ai Za Zhi; 2015 Jun; 18(6):391-6. PubMed ID: 26104898
[TBL] [Abstract][Full Text] [Related]
44. Oncoproteomics: Trials and tribulations.
Zhou L; Li Q; Wang J; Huang C; Nice EC
Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
[TBL] [Abstract][Full Text] [Related]
45. LC-MS/MS-based targeted proteomics quantitatively detects the interaction between p53 and MDM2 in breast cancer.
Zhang W; Zhong T; Chen Y
J Proteomics; 2017 Jan; 152():172-180. PubMed ID: 27826076
[TBL] [Abstract][Full Text] [Related]
46. Genomics and proteomics in predicting cancer outcomes.
Parikh AA; Johnson JC; Merchant NB
Surg Oncol Clin N Am; 2008 Apr; 17(2):257-77, vii. PubMed ID: 18375352
[TBL] [Abstract][Full Text] [Related]
47. Analysis of prostate cancer by proteomics using tissue specimens.
Liu AY; Zhang H; Sorensen CM; Diamond DL
J Urol; 2005 Jan; 173(1):73-8. PubMed ID: 15592032
[TBL] [Abstract][Full Text] [Related]
48. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
[TBL] [Abstract][Full Text] [Related]
49. Proteomics technologies and challenges.
Cho WC
Genomics Proteomics Bioinformatics; 2007 May; 5(2):77-85. PubMed ID: 17893073
[TBL] [Abstract][Full Text] [Related]
50. Recent advances in clinical oncoproteomics.
Jain KK
J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
[TBL] [Abstract][Full Text] [Related]
51. Proteomics analysis in lung cancer: challenges and opportunities.
Kikuchi T; Carbone DP
Respirology; 2007 Jan; 12(1):22-8. PubMed ID: 17207021
[TBL] [Abstract][Full Text] [Related]
52. Cancer biomarker discovery and translation: proteomics and beyond.
Hristova VA; Chan DW
Expert Rev Proteomics; 2019 Feb; 16(2):93-103. PubMed ID: 30556752
[TBL] [Abstract][Full Text] [Related]
53. Technologies to shape the future: proteomics applications in anesthesiology and critical care medicine.
Atkins JH; Johansson JS
Anesth Analg; 2006 Apr; 102(4):1207-16. PubMed ID: 16551925
[TBL] [Abstract][Full Text] [Related]
54. Proteome analysis in the clinical chemistry laboratory: myth or reality?
Righetti PG; Castagna A; Antonucci F; Piubelli C; Cecconi D; Campostrini N; Rustichelli C; Antonioli P; Zanusso G; Monaco S; Lomas L; Boschetti E
Clin Chim Acta; 2005 Jul; 357(2):123-39. PubMed ID: 15970281
[TBL] [Abstract][Full Text] [Related]
55. Recent advances in proteomic technologies applied to cardiovascular disease.
Napoli C; Zullo A; Picascia A; Infante T; Mancini FP
J Cell Biochem; 2013 Jan; 114(1):7-20. PubMed ID: 22886784
[TBL] [Abstract][Full Text] [Related]
56. The molecular make-up of a tumour: proteomics in cancer research.
Kolch W; Mischak H; Pitt AR
Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
[TBL] [Abstract][Full Text] [Related]
57. Oncoproteomics.
Joshi S; Tiwari AK; Mondal B; Sharma A
Clin Chim Acta; 2011 Jan; 412(3-4):217-26. PubMed ID: 20955692
[TBL] [Abstract][Full Text] [Related]
58. A case study on the comparison of different software tools for automated quantification of peptides.
Colaert N; Vandekerckhove J; Martens L; Gevaert K
Methods Mol Biol; 2011; 753():373-98. PubMed ID: 21604136
[TBL] [Abstract][Full Text] [Related]
59. Biopsy Based Proteomic Assay Predicts Risk of Biochemical Recurrence after Radical Prostatectomy.
Saad F; Latour M; Lattouf JB; Widmer H; Zorn KC; Mes-Masson AM; Ouellet V; Saad G; Prakash A; Choudhury S; Han G; Karakiewicz P; Richie JP
J Urol; 2017 Apr; 197(4):1034-1040. PubMed ID: 27725152
[TBL] [Abstract][Full Text] [Related]
60. Proteomics biomarkers for solid tumors: Current status and future prospects.
Belczacka I; Latosinska A; Metzger J; Marx D; Vlahou A; Mischak H; Frantzi M
Mass Spectrom Rev; 2019 Jan; 38(1):49-78. PubMed ID: 29889308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
